Tempus AI (NASDAQ:TEM) & Alternate Health (OTCMKTS:AHGIF) Head to Head Review

Alternate Health (OTCMKTS:AHGIF) and Tempus AI (NASDAQ:TEM) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, valuation, risk, earnings, dividends, profitability and analyst recommendations.

Institutional and Insider Ownership

24.2% of Tempus AI shares are owned by institutional investors. 26.3% of Tempus AI shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Valuation and Earnings

This table compares Alternate Health and Tempus AI”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Alternate Health	N/A	N/A	N/A	N/A	N/A
Tempus AI	$1.27 billion	6.58	-$245.03 million	($1.41)	-33.21

Alternate Health has higher earnings, but lower revenue than Tempus AI.

Profitability

This table compares Alternate Health and Tempus AI’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Alternate Health	N/A	N/A	N/A
Tempus AI	-19.27%	-53.30%	-11.28%

Analyst Recommendations

This is a breakdown of recent recommendations and price targets for Alternate Health and Tempus AI, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Alternate Health	0	0	0	0	0.00
Tempus AI	1	4	8	0	2.54

Tempus AI has a consensus price target of $75.92, indicating a potential upside of 62.12%. Given Tempus AI’s stronger consensus rating and higher possible upside, analysts plainly believe Tempus AI is more favorable than Alternate Health.

Summary

Tempus AI beats Alternate Health on 6 of the 9 factors compared between the two stocks.

About Alternate Health

Alternate Health Corp., a diversified healthcare company, provides cloud based software solutions in Canada. It offers medical practice and controlled substance management software, blood analysis and toxicology labs, clinical research, continuing education programs, nutraceutical products, and security and control services to the medical cannabis industry. The company is headquartered in Toronto, Canada.

About Tempus AI

Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. Tempus AI Inc. is based in CHICAGO.